![Potential drug to target a rare childhood brain tumour – ICR](https://oncodaily.com/pub/uploads/2023/08/logo_share-e1725575729126.jpg)
Photo from The Institute of Cancer Research/LinkedIn
Sep 7, 2024, 15:31
Potential drug to target a rare childhood brain tumour – ICR
The Institute of Cancer Research (ICR) shared a post on LinkedIn:
“News: Research reveals a potential drug to target a rare childhood brain tumour.
ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.
Read more about the research, funded by The Brain Tumour Charity.”
Source: The Institute of Cancer Research/LinkedIn
More posts featuring The Institute of Cancer Research on oncodaily.com
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023